B-type cyclins are regulatory subunits with distinct roles in the cell cycle. To date, at least three subtypes of B-type cyclins (B1, B2, and B3) have been identified in vertebrates. Previously, we reported the characterization and expression profiles of cyclin B1 and B2 during gametogenesis in the rainbow trout (). In this paper, we isolated another subtype of cyclin B, cyclin B3 (CB3), from a cDNA library of the rainbow trout oocyte. The full-length CB3 cDNA (2,093 bp) has an open reading frame (1,248 bp) that encodes a protein of 416 amino acid residues. The CB3 transcript was widely distributed in all the examined tissues, namely, eye, gill, spleen, brain, heart, kidney, stomach, skin, muscle, and, especially, gonad. Northern blot analysis indicated only one form of the CB3 transcript in the testis and ovary. hybridization revealed that, in contrast to cyclin B1 and B2 transcripts, CB3 transcripts were localized in the oocytes, spermatocytes, and spermatogonia. These findings strongly suggest that CB3 plays a role not only as a mitotic cyclin in spermatogonial proliferation during early spermatogenesis but also during meiotic maturation of the spermatocyte and oocyte in the rainbow trout.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660826 | PMC |
http://dx.doi.org/10.7717/peerj.7396 | DOI Listing |
J Immunol
January 2025
Biotechnology Department, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Upon antigen encounter, B cells start a differentiation process toward antibody-secreting cells (ASCs), initially plasmablasts, and eventually long-lived plasma cells. All these ASCs specialize in secreting important amounts of antibodies and usually lose other functionalities of naïve B cells. This differentiation process is scarcely characterized in teleost fish, in which B cells have been shown to share many functional and phenotypic characteristics of mammalian B1 innate subsets.
View Article and Find Full Text PDFFood Res Int
April 2025
Food Science and Technology Research Institute, ACECR Mashhad Branch, Mashhad, Iran.
This study was conducted to evaluate the purification of antioxidant peptides from the rainbow trout viscera using by enzymatic hydrolysis and to measure the amino acid profile of the peptide part with more antioxidant properties. Two concentrations of alcalase were used to hydrolyse fish viscera (1 % and 2 %). The hydrolyzate was fractionated and purified with ultra-filtration membranes (<30, <10, and < 3 kDa) and RP-HPLC (Reversed-phase high-performance liquid chromatography) and evaluation for antioxidant properties by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS) radical scavenging assays.
View Article and Find Full Text PDFFish Physiol Biochem
March 2025
Faculty of Fisheries and Protection of Waters, South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Institute of Aquaculture and Protection of Waters, University of South Bohemia in České BuděJovice, Husova trida 458/102, České Budějovice, 37005, Czech Republic.
Exogenous enzymes are used to enhance ingredient digestibility, overall fish growth, and feed utilization; however, different administration methods have not been extensively studied. In this study, a mixture of carbohydrases (α-amylase, cellulase, xylanase, and β-glucanase) was applied before (at B3, B6, B12, and B24 hours), during (D), or after (A) the production of high-carbohydrate diets (33% carbohydrates) to assess their effects on the growth and feed utilization of rainbow trout. The enzymes were added to the diets at the minimum required levels, determined by a reducing sugar test with dinitrosalicylic acid (DNS) based on the available wheat flour and soybean meal in the diet.
View Article and Find Full Text PDFVaccine
March 2025
UMR 5305: Laboratoire de Biologie Tissulaire et d'Ingénierie Thérapeutique, Institut de Biologie et Chimie des Protéines, CNRS/Université Claude Bernard Lyon 1, 7 passage du Vercors, 69007 Lyon, France. Electronic address:
mRNA vaccines are poised to revolutionize disease prevention, following the approval of their administration to humans against SARS-CoV-2. Although they have been extensively studied for human applications, their potential in the veterinary field has not been explored yet. No mRNA vaccines have yet been reported for fish, despite the urgent need for new vaccines against emerging pathogens in aquaculture.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!